Randomized clinical trials in thrombotic thrombocytopenic purpura: where do we go from here?
- 21 September 2006
- journal article
- Published by Wiley in Transfusion
- Vol. 46 (10) , 1659-1662
- https://doi.org/10.1111/j.1537-2995.2006.00986.x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh‐frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraTransfusion, 2006
- Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune‐mediated disordersJournal of Clinical Apheresis, 2006
- Treatment of thrombotic thrombocytopenic purpuraVox Sanguinis, 2006
- Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura‐hemolytic uremic syndromeTransfusion, 2005
- Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 casesBlood, 2005
- Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S‐59) and ultraviolet A lightTransfusion, 2005
- Thrombotic thrombocytopenic purpura: Early and late respondersAmerican Journal of Hematology, 1997
- Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 1996
- Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institutionArchives of internal medicine (1960), 1992
- Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpuraAmerican Journal of Hematology, 1990